Volta Medical SAS

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA

Volta Medical annoncera les résultats de l’essai clinique randomisé TAILORED-AF lors des sessions Late-Breaking du congrès Heart Rhythm 2024 à Boston, MA, États-Unis

Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced

Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication

Volta Medical führt neuartige, auf Künstlicher Intelligenz basierende Technologie VX1 zur Behandlung von persistierenden Herzrhythmusstörungen an ausgewählten klinischen Zentren in Deutschland ein